HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yumi Itoh Selected Research
Yumi Itoh Research Topics
Disease
2
COVID-19
01/2023 - 01/2022
2
Infections
04/2022 - 01/2022
2
Hepatitis B
04/2022 - 03/2021
2
Osteoarthritis
03/2016 - 01/2016
2
Hypertrophy
03/2016 - 01/2016
2
Melanoma (Melanoma, Malignant)
01/2016 - 01/2011
1
Severe Acute Respiratory Syndrome
11/2023
1
Pulmonary Fibrosis (Fibrosing Alveolitis)
04/2023
1
Connective Tissue Diseases (Connective Tissue Disease)
04/2023
1
Interstitial Lung Diseases (Interstitial Lung Disease)
04/2023
1
Disease Progression
01/2022
1
Ischemia
12/2018
1
Hypoxia (Hypoxemia)
12/2018
1
Reperfusion Injury
12/2018
1
Hermanski-Pudlak Syndrome (Hermansky-Pudlak Syndrome)
01/2016
1
Colitis
01/2016
1
Crohn Disease (Crohn's Disease)
01/2016
1
Diarrhea
01/2016
1
Hepatocellular Carcinoma (Hepatoma)
07/2015
1
Septic Shock (Toxic Shock Syndrome)
06/2015
1
Alzheimer Disease (Alzheimer's Disease)
12/2014
1
Cardiovascular Diseases (Cardiovascular Disease)
08/2012
1
Heart Failure
08/2012
1
Insulin Resistance
08/2012
1
Myocardial Infarction
08/2012
1
Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2012
1
Lipid Metabolism Disorders (Metabolism Disorders, Lipid)
01/2012
1
Experimental Melanoma
12/2010
Drug/Important Bio-Agent (IBA)
3
Salts
IBA
03/2016 - 06/2015
3
pterosin B
IBA
03/2016 - 07/2015
2
Proteins (Proteins, Gene)
FDA Link
04/2022 - 03/2021
2
Lipopolysaccharides
IBA
12/2018 - 06/2015
2
carnosol
IBA
12/2018 - 01/2016
2
Phosphotransferases (Kinase)
IBA
03/2016 - 06/2015
2
Mechanistic Target of Rapamycin Complex 1
IBA
01/2011 - 12/2010
1
Messenger RNA (mRNA)
IBA
11/2023
1
Carbon Monoxide
IBA
04/2023
1
nintedanib
IBA
04/2023
1
Aerosols
IBA
01/2023
1
hepatitis B hyperimmune globulin
IBA
04/2022
1
Monoclonal Antibodies
IBA
04/2022
1
Antibodies
IBA
04/2022
1
Immunoglobulins (Immunoglobulin)
IBA
04/2022
1
Amino Acids
FDA Link
04/2022
1
Membrane Proteins (Integral Membrane Proteins)
IBA
04/2022
1
Therapeutic Uses
IBA
01/2022
1
Virulence Factors (Pathogenicity Factors)
IBA
01/2022
1
Interleukin-6 (Interleukin 6)
IBA
12/2018
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
12/2018
1
Microphthalmia-Associated Transcription Factor
IBA
01/2016
1
Dextran Sulfate
IBA
01/2016
1
Nonsense Codon (Nonsense Mutation)
IBA
01/2016
1
Melanins (Melanin)
IBA
01/2016
1
Phosphorylase Kinase (Phosphorylase Kinase, Glycogen)
IBA
07/2015
1
Glycogen
IBA
07/2015
1
Glucose (Dextrose)
FDA Link
Generic
07/2015
1
N-Methyl-D-Aspartate Receptors (NMDA Receptors)
IBA
12/2014
1
Memantine (Namenda)
FDA Link
12/2014
1
N-Methylaspartate (NMDA)
IBA
12/2014
1
Brain Natriuretic Peptide (Natrecor)
FDA Link
08/2012
1
HDL Cholesterol
IBA
08/2012
1
Triglycerides (Triacylglycerol)
IBA
08/2012
1
Uric Acid (Urate)
IBA
08/2012
1
Adiponectin
IBA
08/2012
1
Alitretinoin
FDA Link
01/2012
1
3,3',7-trihydroxy-4'-methoxyflavon
IBA
01/2011
1
fisetin
IBA
01/2011
Therapy/Procedure
2
Therapeutics
04/2022 - 01/2022
1
Intra-Articular Injections
03/2016